Won't get vaccinated for now, priority groups should be served first: Shivraj Chouhan

Video Credit: ANI
Published on January 4, 2021 - Duration: 01:10s

Won't get vaccinated for now, priority groups should be served first: Shivraj Chouhan

Madhya Pradesh Chief Minister Shivraj Singh Chouhan on January 04 said that he will not get vaccinated against COVID-19 for now, as he wants the priority groups to be served first.

"I have decided that I will not get vaccinated for now, first it should be administered to others.

My turn should come afterwards, we have to work to ensure that priority groups are administered with the vaccine," said CM Shivraj Singh Chouhan.

DCGI granted approval to vaccines of Serum Institute of India and Bharat Biotech for restricted use in emergency situation on January 03.


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions



COVID-19

Disease caused by severe acute respiratory syndrome coronavirus 2
As the world collectively battles the Covid-19 pandemic, scientists are now looking towards developing a vaccine which can train the human immune system to ward..
Credit: IndiaTimes - Published 2 hours ago

India on Tuesday reported 42,640 daily new Covid cases, the lowest in over three months, pushing the country's total tally to 29,977,861, according to the data..
Credit: IndiaTimes - Published 3 hours ago



Serum Institute of India

Indian biotechnology and biopharmaceuticals company
The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with US pharmaceutical firm Novovax.
Credit: DNA - Published 5 days ago

Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield..
Credit: IndiaTimes - Published 1 week ago

Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
Credit: DNA - Published 1 week ago

The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major..
Credit: IndiaTimes - Published 1 week ago


Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotechโ€™s expression of..
Credit: IndiaTimes - Published 5 days ago

The World Health Organisation (WHO) has accepted Bharat Biotechโ€™s expression of interest (EoI) for the emergency use listing (EUL) of India's first..
Credit: IndiaTimes - Published 5 days ago

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use..
Credit: IndiaTimes - Published 5 days ago

Related videos from verified sources

CM Shivraj launches 'Pulse Polio Programme' in MP 01:36
Video credit: ANI - Published on January 31, 2021 

'Lying is foundation of Congress': CM Chouhan targets Rahul Gandhi 01:43
Video credit: ANI - Published on January 25, 2021 

Shivraj Singh doesn't have right to be the Chief Minister: Digvijaya Singh 01:16
Video credit: ANI - Published on January 24, 2021 

You might like